UBS Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Buy |
48,038
+1,890
| +4% | +$14.3K | ﹤0.01% | 5075 |
|
|
2025
Q1 | $255K | Buy |
46,148
+14,996
| +48% | +$82.8K | ﹤0.01% | 5142 |
|
|
2024
Q4 | $179K | Buy |
31,152
+1,816
| +6% | +$10.4K | ﹤0.01% | 5316 |
|
|
2024
Q3 | $304K | Buy |
29,336
+19,641
| +203% | +$203K | ﹤0.01% | 4402 |
|
|
2024
Q2 | $126K | Sell |
9,695
-10,620
| -52% | -$138K | ﹤0.01% | 4880 |
|
|
2024
Q1 | $355K | Sell |
20,315
-915
| -4% | -$16K | ﹤0.01% | 4328 |
|
|
2023
Q4 | $200K | Buy |
21,230
+8,272
| +64% | +$77.8K | ﹤0.01% | 4605 |
|
|
2023
Q3 | $145K | Sell |
12,958
-30,537
| -70% | -$341K | ﹤0.01% | 4488 |
|
|
2023
Q2 | $931K | Buy |
43,495
+33,183
| +322% | +$710K | ﹤0.01% | 3372 |
|
|
2023
Q1 | $417K | Sell |
10,312
-27,704
| -73% | -$1.12M | ﹤0.01% | 3836 |
|
|
2022
Q4 | $1.77M | Buy |
38,016
+35,838
| +1,645% | +$1.67M | ﹤0.01% | 2664 |
|
|
2022
Q3 | $113K | Sell |
2,178
-10,001
| -82% | -$519K | ﹤0.01% | 4563 |
|
|
2022
Q2 | $576K | Sell |
12,179
-13,125
| -52% | -$621K | ﹤0.01% | 3258 |
|
|
2022
Q1 | $1.8M | Sell |
25,304
-15,060
| -37% | -$1.07M | ﹤0.01% | 2740 |
|
|
2021
Q4 | $3.02M | Buy |
40,364
+9,159
| +29% | +$685K | ﹤0.01% | 2539 |
|
|
2021
Q3 | $1.77M | Buy |
31,205
+20,191
| +183% | +$1.15M | ﹤0.01% | 2829 |
|
|
2021
Q2 | $485K | Sell |
11,014
-15,216
| -58% | -$670K | ﹤0.01% | 3775 |
|
|
2021
Q1 | $1.29M | Buy |
26,230
+26,136
| +27,804% | +$1.29M | ﹤0.01% | 3134 |
|
|
2020
Q4 | $4K | Buy |
+94
| New | +$4K | ﹤0.01% | 6871 |
|
|
2020
Q3 | – | Sell |
-456
| Closed | -$23K | – | 7149 |
|
|
2020
Q2 | $23K | Sell |
456
-4,447
| -91% | -$224K | ﹤0.01% | 5613 |
|
|
2020
Q1 | $252K | Sell |
4,903
-990
| -17% | -$50.9K | ﹤0.01% | 3732 |
|
|
2019
Q4 | $364K | Sell |
5,893
-21,680
| -79% | -$1.34M | ﹤0.01% | 4159 |
|
|
2019
Q3 | $1.66M | Buy |
27,573
+21,376
| +345% | +$1.28M | ﹤0.01% | 2784 |
|
|
2019
Q2 | $523K | Buy |
6,197
+6,069
| +4,741% | +$512K | ﹤0.01% | 3514 |
|
|
2019
Q1 | $13K | Sell |
128
-30,489
| -100% | -$3.1M | ﹤0.01% | 5798 |
|
|
2018
Q4 | $2.17M | Buy |
30,617
+18,296
| +148% | +$1.3M | ﹤0.01% | 2376 |
|
|
2018
Q3 | $1.05M | Buy |
12,321
+7,450
| +153% | +$637K | ﹤0.01% | 3112 |
|
|
2018
Q2 | $565K | Sell |
4,871
-22,898
| -82% | -$2.66M | ﹤0.01% | 3460 |
|
|
2018
Q1 | $2.25M | Buy |
27,769
+25,706
| +1,246% | +$2.08M | ﹤0.01% | 2461 |
|
|
2017
Q4 | $121K | Sell |
2,063
-5,383
| -72% | -$316K | ﹤0.01% | 4304 |
|
|
2017
Q3 | $349K | Buy |
7,446
+7,125
| +2,220% | +$334K | ﹤0.01% | 3684 |
|
|
2017
Q2 | $12K | Buy |
321
+50
| +18% | +$1.87K | ﹤0.01% | 5696 |
|
|
2017
Q1 | $8K | Sell |
271
-8,560
| -97% | -$253K | ﹤0.01% | 5818 |
|
|
2016
Q4 | $296K | Buy |
8,831
+6,176
| +233% | +$207K | ﹤0.01% | 3666 |
|
|
2016
Q3 | $71K | Sell |
2,655
-9,337
| -78% | -$250K | ﹤0.01% | 4366 |
|
|
2016
Q2 | $264K | Buy |
11,992
+11,003
| +1,113% | +$242K | ﹤0.01% | 3577 |
|
|
2016
Q1 | $29K | Sell |
989
-26,640
| -96% | -$781K | ﹤0.01% | 5098 |
|
|
2015
Q4 | $912K | Buy |
27,629
+20,500
| +288% | +$677K | ﹤0.01% | 2752 |
|
|
2015
Q3 | $258K | Buy |
7,129
+6,690
| +1,524% | +$242K | ﹤0.01% | 3541 |
|
|
2015
Q2 | $20K | Buy |
439
+139
| +46% | +$6.33K | ﹤0.01% | 5487 |
|
|
2015
Q1 | $9K | Sell |
300
-4,050
| -93% | -$122K | ﹤0.01% | 5912 |
|
|
2014
Q4 | $221K | Buy |
+4,350
| New | +$221K | ﹤0.01% | 3713 |
|